249 related articles for article (PubMed ID: 19602482)
1. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
2. Increased Rac1b expression sustains colorectal tumor cell survival.
Matos P; Jordan P
Mol Cancer Res; 2008 Jul; 6(7):1178-84. PubMed ID: 18644982
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
4. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
[TBL] [Abstract][Full Text] [Related]
5. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells.
Esufali S; Charames GS; Pethe VV; Buongiorno P; Bapat B
Cancer Res; 2007 Mar; 67(6):2469-79. PubMed ID: 17363564
[TBL] [Abstract][Full Text] [Related]
7. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
[TBL] [Abstract][Full Text] [Related]
9. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
10. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors.
Jordan P; Brazåo R; Boavida MG; Gespach C; Chastre E
Oncogene; 1999 Nov; 18(48):6835-9. PubMed ID: 10597294
[TBL] [Abstract][Full Text] [Related]
11. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
13. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms.
Esufali S; Charames GS; Bapat B
FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911
[TBL] [Abstract][Full Text] [Related]
14. The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.
Gonçalves V; Matos P; Jordan P
RNA; 2008 Dec; 14(12):2538-49. PubMed ID: 18952824
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
Robard C; Daviau A; Di Fruscio M
Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
[TBL] [Abstract][Full Text] [Related]
16. XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.
Mangs AH; Speirs HJ; Goy C; Adams DJ; Markus MA; Morris BJ
Nucleic Acids Res; 2006; 34(17):4976-86. PubMed ID: 16982639
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
19. SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms.
Blaustein M; Quadrana L; Risso G; Mata Mde L; Pelisch F; Srebrow A
J Cell Biochem; 2009 Jul; 107(4):826-33. PubMed ID: 19441081
[TBL] [Abstract][Full Text] [Related]
20. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
